Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Techniques & Tools

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2024 / Articles / Dec / A DNA-Based Method of Anticounterfeiting
Discovery & Development Dosage Forms Drug Delivery Formulation Ingredients Drug Delivery

A DNA-Based Method of Anticounterfeiting

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products

By Stephanie Vine 12/09/2024 1 min read

Share

Researchers from ETH Zurich have suggested that DNA-based tags mixed into pharmaceutical formulations could be an effective anticounterfeiting method. Their approach used chemical unclonable functions (CUFs) based on pools of short random DNA oligos. Usually, these types of tags would need a complex verification process, but the team was able to develop what they described as a “low-tech workflow that is fast and cost-effective.”

Pharmaceutical counterfeiting is more than just a supply chain problem – it’s a health crisis, particularly in certain regions. According to the World Health Organization, around 10.5 percent of drugs in low- and middle-income countries are counterfeit or substandard. Typically, anticounterfeit efforts use packaging features such as tamper-evident seals, RFID tags, and QR codes, but these become useless if the packaging is removed.

By embedding security directly into the product, CUFs offer a practical, long-lasting alternative to packaging-based anticounterfeit methods. The tags are made up of pools of random DNA sequences, creating a cryptographic signature that gives each batch of medicine a unique identity akin to a DNA. When tested, authentic products produce a specific response that a counterfeit wouldn’t match.

The researchers used acetaminophen to demonstrate their method. CUFs were integrated using silica nanoparticles, which stabilizes the DNA against environmental changes and potential degradation. The team found that their tags were detectable at concentrations below 50 nanograms per gram, making them both safe for patients and robust enough to withstand pharmaceutical storage conditions.

Through accelerated stability testing, the researchers determined that the tags remained stable for years, surpassing the standard shelf life of most pharmaceuticals. This means that CUFs could provide lasting counterfeit protection from production to end use, without compromising the drug’s integrity. CUFs also offer strong resistance to tampering or dilution attempts. Because each DNA sequence is unique, replicating or altering these tags would be both costly and complex for counterfeiters. CUFs are cryptographically secure, producing an unreplicable response that cannot be cloned or predicted, even if the DNA sequence is known.

The researchers conclude, “The method has a high level of security against replication and dilution attacks and enables labeling on the product level, the batch level or even the dose level. The implemented formulation is versatile in its use and is suitable for solid, liquid or gel formulations and polymers. Thus, chemical unclonable functions are a promising tool for the fight against counterfeit products in pharmaceuticals and beyond.”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

Squid-Inspired Drug Delivery
Drug Delivery Dosage Forms Formulation
Squid-Inspired Drug Delivery

April 3, 2025

4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally

Schizophrenia and the Future of Long-Acting Therapeutics
Formulation Dosage Forms Drug Delivery
Schizophrenia and the Future of Long-Acting Therapeutics

March 11, 2025

5 min read

Long-acting injectables help with adherence, but what if an unfolding pill could provide an oral option?

Co-Crystals Shine in Innovation Awards
Dosage Forms Drug Delivery Formulation Small Molecules
Co-Crystals Shine in Innovation Awards

March 14, 2025

1 min read

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction

Three Trends to Watch in Oral Solid Dosages
Dosage Forms Formulation Small Molecules
Three Trends to Watch in Oral Solid Dosages

February 19, 2025

4 min read

Oral solid dosages remain the world’s most popular dosage form, but their increasing complexity brings challenges.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.